Results 21 to 30 of about 6,225,689 (197)
Liquid Biopsy: Past, Present, and Future. [PDF]
Liquid biopsy has expanded from cancer genotyping to a broader strategy for probing both oncologic and nononcologic conditions through circulating analytes and multilayer molecular readouts. This review traces the field's past, present, and future—summarizing where liquid biopsy is most actionable today, why performance varies across contexts, and ...
Liu J +8 more
europepmc +2 more sources
Liquid Biopsy: Detection of Circulating Tumor Cells in Esophageal Squamous Cell Carcinoma
Circulating tumor cells (CTC) harvested in the blood of patients with esophageal squamous cell carcinoma (ESCC) are associated with certain clinical pathological parameters as well as patients’ prognosis and response to chemoradiation.
Lam, AK +5 more
core +1 more source
CTC-5: A novel digital pathology approach to characterise circulating tumour cell biodiversity
Metastatic progression and tumor evolution complicates the clinical management of cancer patients. Circulating tumor cell (CTC) characterization is a growing discipline that aims to elucidate tumor metastasis and evolution processes.
O'Riain, C. +87 more
core +1 more source
StarDist Image Segmentation Improves Circulating Tumor Cell Detection [PDF]
SIMPLE SUMMARY: Automated enumeration of circulating tumor cells (CTC) from immunofluorescence images starts with a selection of areas containing potential CTC.
Michiel Stevens +11 more
core +1 more source
Cultured circulating tumor cells and their derived xenografts for personalized oncology
Recent cancer research has demonstrated the existence of circulating tumor cells (CTCs) in cancer patient's blood. Once identified, CTC biomarkers will be invaluable tools for clinical diagnosis, prognosis and treatment.
Ruoxiang Wang +14 more
doaj +1 more source
Liver transplantation (LT) can benefit the long-term survival of hepatocellular carcinoma (HCC) patients. We hypothesized that circulating tumor cell (CTC) levels and subtypes are intimately associated with metastasis status of HCC patients.
Zhuang Li +6 more
doaj +1 more source
Elucidating PI3K/AKT/PTEN Pathway Alterations at Single-Cell Level in CTCs From HR+/HER2- Metastatic Breast Cancer. [PDF]
Single CTC analysis revealed extensive inter‐ and intra‐patient heterogeneity of PI3K/AKT/PTEN pathway alterations in HR+/HER2− metastatic breast cancer, capturing both SNVs and CNAs, including PTEN loss‐of‐function events. Longitudinal CTC profiling also uncovered dynamic clonal evolution, highlighting its potential to complement tissue and ctDNA ...
Rossi T +10 more
europepmc +2 more sources
Liquid Biopsy in Clinical Management of Breast, Lung, and Colorectal Cancer
Examination of tumor molecular characteristics by liquid biopsy is likely to greatly influence personalized cancer patient management. Analysis of circulating tumor DNA (ctDNA), circulating tumor cells (CTCs), and tumor-derived exosomes, all collectively
Ivana Bratić Hench +2 more
doaj +1 more source
The current FDA-approved whole blood stabilization method for circulating tumor cell (CTC) isolation suffers from RNA degradation. Here the authors combine hypothermic preservation and antiplatelet strategies to stabilize whole blood up to 72 h without ...
Keith H. K. Wong +18 more
doaj +1 more source
Microfluidic Isolation of Circulating Tumor Cell Clusters by Size and Asymmetry
Circulating tumor cell clusters (CTC clusters) are potent initiators of metastasis and potentially useful clinical markers for patients with cancer. Although there are numerous devices developed to isolate individual circulating tumor cells from blood ...
Sam H. Au +9 more
doaj +1 more source

